What is Glioblastoma (GBM)?
Glioblastoma, referred to simply as GBM, is the deadliest type of brain cancer. GBM is widely regarded as incurable and universally fatal, killing 95% of patients within five years of diagnosis. GBM survival rates have not improved in…
This past fall saw considerable progress in the development of GBM AGILE, the brain cancer clinical trial initiative whose early-stage planning has long been supported by the Asian Fund for Cancer Research. Not only was an acting head hired to run the…
A global clinical trial to allow more patients to quickly share benefits of more effective treatments